Nordion to Release Fourth Quarter and Fiscal 2012 Financial Results
OTTAWA, Ontario -- January 21, 2013
Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and
services to the global health science market, today announced that the Company
will report its fourth quarter and fiscal 2012 financial results before
markets open on January 28, 2013.
Fourth Quarter and Fiscal 2012 Conference Call
The Company will also host an analyst conference call with Steve West, Chief
Executive Officer and Peter Dans, Chief Financial Officer, to discuss the
results. The call will be webcast live on January 28, 2013 at 10:00 a.m. EST.
Interested parties may access the live webcast of the conference call from the
Nordion website at www.nordion.com. To participate, please dial 1-866-223-7781
(toll-free North America) or 1-416-340-8018 (International). Following the
call, an audio archive will be available on the website at www.nordion.com.
About Nordion Inc.
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science company that
provides market-leading products used for the prevention, diagnosis and
treatment of disease. We are a leading provider of targeted therapies,
sterilization technologies and medical isotopes that benefit the lives of
millions of people in more than 60 countries around the world. Our products
are used daily by pharmaceutical and biotechnology companies, medical-device
manufacturers, hospitals, clinics and research laboratories. Nordion has
approximately 500 highly skilled employees worldwide. Find out more at
www.nordion.com and follow us at http://twitter.com/NordionInc.
Tanya Pobuda, (613) 592-3400 x. 2280
Ana Raman, (613) 595-4580
Press spacebar to pause and continue. Press esc to stop.